In colon cancer cells, curcuminoid treatment induced ROS production which disrupted the miR-27a/Sp/cyclin B/cdc2 axis and inhibited subsequent G2-M transition, leading to enhanced growth inhibition of 5-FU [48, 49]. Here, TFF2 is linked to colonic neoplasm.